Skip to main content

Following a $110 Million Move

Consumer health staple giant gets a big inside buy

Every day, we sift through the filings to spot where the real conviction lies โ€“ cutting through the noise to highlight the most meaningful insider moves.

๐Ÿ“Œ Kenvue $KVUE โ€” Starboard Value LP disclosed a Form 4 purchase totaling $110.99 Million.
 
A massive transaction that immediately stands out in a defensive consumer staple. This is sizing that reflects strategic intent, not passive exposure.

๐Ÿ“Œ Amcor Plc $AMCR โ€” CFO Stephen R. Scherger bought $1,006,982 in his latest Form 1.

When the companyโ€™s top financial executive steps in with size, itโ€™s always worth paying attention.

Hereโ€™s The Hot Corner, with data from December 15, 2025:

๐Ÿ“Œ Kymera Therapeutics $KYMR โ€” Biotechnology Value Fund lifted its 13D stake from 7.22% to 8.50%.
 
Specialist biotech capital pressing its position as the stock continues to push into all-time highs.

๐Ÿ“Œ NextDecade $NEXT โ€” Hanwha Aerospace disclosed a Form 4 purchase of $9.40 Million.
 
Continued accumulation from the Korean giant in this strategic partner.